These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Using the upper limit of vulnerability to assess defibrillation efficacy at implantation of ICDs. Swerdlow CD; Shehata M; Chen PS Pacing Clin Electrophysiol; 2007 Feb; 30(2):258-70. PubMed ID: 17338725 [TBL] [Abstract][Full Text] [Related]
24. Effects of polarity on defibrillation thresholds using a biphasic waveform in a hot can electrode system. Yamanouchi Y; Mowrey KA; Nadzam GR; Hills DG; Kroll MW; Brewer JE; Donohoo AM; Wilkoff BL; Tchou PJ Pacing Clin Electrophysiol; 1997 Dec; 20(12 Pt 1):2911-6. PubMed ID: 9455750 [TBL] [Abstract][Full Text] [Related]
26. Defibrillation with a minimally invasive direct cardiac massage device. Walcott GP; Booker RG; Ideker RE Resuscitation; 2002 Dec; 55(3):301-7. PubMed ID: 12458067 [TBL] [Abstract][Full Text] [Related]
27. Detection of the defibrillation threshold using the upper limit of vulnerability following defibrillator implantation. Kirilmaz A; Dokumaci B; Uzun M; Kilicaslan F; Dinckal MH; Yucel O; Karaca M Pacing Clin Electrophysiol; 2005 Jun; 28(6):498-505. PubMed ID: 15955181 [TBL] [Abstract][Full Text] [Related]
28. Influence of malpositioned transvenous leads on defibrillation efficacy with and without a subcutaneous array electrode. Usui M; Walcott GP; KenKnight BH; Walker RG; Rollins DL; Smith WM; Ideker RE Pacing Clin Electrophysiol; 1995 Nov; 18(11):2008-16. PubMed ID: 8552514 [TBL] [Abstract][Full Text] [Related]
29. Effects of n-3 polyunsaturated fatty acid on upper limit of vulnerability shocks. Chattipakorn N; Shinlapawittayatorn K; Sungnoon R; Chattipakorn SC Int J Cardiol; 2006 Mar; 107(3):299-302. PubMed ID: 16503251 [TBL] [Abstract][Full Text] [Related]
30. Low-energy endocardial defibrillation using an axillary or a pectoral thoracic electrode location. Saksena S; DeGroot P; Krol RB; Raju R; Mathew P; Mehra R Circulation; 1993 Dec; 88(6):2655-60. PubMed ID: 8252676 [TBL] [Abstract][Full Text] [Related]
31. Biphasic waveform defibrillation using a three-electrode transvenous lead system in humans. Marks ML; Johnson G; Hofer BO; Bardy GH J Cardiovasc Electrophysiol; 1994 Feb; 5(2):103-8. PubMed ID: 8186880 [TBL] [Abstract][Full Text] [Related]
32. Assessment of adequate safety margin using single coupling interval-upper limit of vulnerability test. Patel MB; Pandya K; Thakur RK Pacing Clin Electrophysiol; 2014 Jan; 37(1):95-103. PubMed ID: 24033830 [TBL] [Abstract][Full Text] [Related]
33. Improved defibrillation thresholds with large contoured epicardial electrodes and biphasic waveforms. Dixon EG; Tang AS; Wolf PD; Meador JT; Fine MJ; Calfee RV; Ideker RE Circulation; 1987 Nov; 76(5):1176-84. PubMed ID: 3665001 [TBL] [Abstract][Full Text] [Related]
34. The Relationship Between Cardiac Vulnerability and Restitution Properties of the Ventricular Activation Recovery Interval. Yamashita S; Yoshida A; Fukuzawa K; Nakanishi T; Matsumoto A; Konishi H; Ichibori H; Hyogo K; Imada H; Hirata K J Cardiovasc Electrophysiol; 2015 Jul; 26(7):768-73. PubMed ID: 25810143 [TBL] [Abstract][Full Text] [Related]
35. Measurement of the upper limit of vulnerability during defibrillator implantation can substitute defibrillation threshold measurement. Bessho R; Tanaka S Int J Artif Organs; 1998 Mar; 21(3):151-60. PubMed ID: 9622114 [TBL] [Abstract][Full Text] [Related]
36. Effects of lidocaine on shock-induced vulnerability. Li L; Nikolski V; Efimov IR J Cardiovasc Electrophysiol; 2003 Oct; 14(10 Suppl):S237-48. PubMed ID: 14760929 [TBL] [Abstract][Full Text] [Related]
37. Effective defibrillation in pigs using interleaved and common phase sequential biphasic shocks. Guse PA; Rollins DL; Krassowska W; Wolf PD; Smith WM; Ideker RE Pacing Clin Electrophysiol; 1993 Aug; 16(8):1719-34. PubMed ID: 7690941 [TBL] [Abstract][Full Text] [Related]
38. Discrepancies between the upper limit of vulnerability and defibrillation threshold: prevalence and clinical predictors. Gurevitz OT; Friedman PA; Glikson M; Trusty JM; Ballman KV; Rosales AG; Hayes DL; Hammill SC; Swerdlow CD J Cardiovasc Electrophysiol; 2003 Jul; 14(7):728-32. PubMed ID: 12930253 [TBL] [Abstract][Full Text] [Related]
39. Upper limit of vulnerability determination during implantable cardioverter-defibrillator placement to minimize ventricular fibrillation inductions. Glikson M; Gurevitz OT; Trusty JM; Sharma V; Luria DM; Eldar M; Shen WK; Rea RF; Hammill SC; Friedman PA Am J Cardiol; 2004 Dec; 94(11):1445-9. PubMed ID: 15566924 [TBL] [Abstract][Full Text] [Related]
40. The effect of phase separation on biphasic waveform defibrillation. Cooper RA; Wallenius ST; Smith WM; Ideker RE Pacing Clin Electrophysiol; 1993 Mar; 16(3 Pt 1):471-82. PubMed ID: 7681199 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]